S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RLMD Relmada Therapeutics Inc

0.2712

-0.0153 (-5.34%)

Mar 10 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics Inc News

Form 8-K - Current report
Thursday 6 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 6 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 9 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 December 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
Monday 16 September 2024 (6 months ago) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Thursday 12 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

More Relmada Therapeutics Inc News Articles

Intesa Sanpaolo

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions